Choksi Laboratories Intrinsic Value
CHOKSILA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹38.04 | ₹30.43 - ₹45.65 | -70.0% | EPS: ₹2.40, Sector P/E: 12x |
| Book Value Method | asset | ₹34.29 | ₹30.86 - ₹37.72 | -73.0% | Book Value/Share: ₹34.29, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹50.29 | ₹45.26 - ₹55.32 | -60.3% | Revenue/Share: ₹62.86, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹97.00 | ₹87.30 - ₹106.70 | -23.5% | EBITDA: ₹12.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹232.86 | ₹186.29 - ₹279.43 | +83.6% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹38.40 | ₹34.56 - ₹42.24 | -69.7% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹38.04 | ₹34.24 - ₹41.84 | -70.0% | Revenue Growth: 10.0%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹63.40 | ₹57.06 - ₹69.74 | -50.0% | ROE: 8.3%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹43.03 | ₹38.73 - ₹47.33 | -66.1% | EPS: ₹2.40, BVPS: ₹34.29 |
Want to compare with current market value? Check CHOKSILA share price latest .
Valuation Comparison Chart
CHOKSILA Intrinsic Value Analysis
What is the intrinsic value of CHOKSILA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Choksi Laboratories (CHOKSILA) is ₹43.03 (median value). With the current market price of ₹126.80, this represents a -66.1% variance from our estimated fair value.
The valuation range spans from ₹34.29 to ₹232.86, indicating ₹34.29 - ₹232.86.
Is CHOKSILA undervalued or overvalued?
Based on our multi-method analysis, Choksi Laboratories (CHOKSILA) appears to be trading above calculated value by approximately 66.1%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.89 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.71 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 8.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.68x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Choksi Laboratories
Additional stock information and data for CHOKSILA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹12 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹8 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |